Intranasal Oxytocin for Adult Autism Spectrum Disorder: A Randomized Double-Blind Controlled Trial

This randomized controlled trial evaluates intranasal oxytocin as a potential therapeutic intervention for adults with autism spectrum disorder. The study uses rigorous double-blind methodology to assess efficacy, though broader evidence on oxytocin for ASD remains mixed and inconclusive.